Sanofi-aventis Video Q&A: CEO Chris Viehbacher Comments on Q3 '09 Earning and Outlook
More News related to SAN
- New GoMeals(TM) iPhone Application from sanofi-aventis U.S. to Help People with Diabetes Eat Healthy Anywhere, Anytime
- Santander Celebrates Five Years in the UK
- 2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer
- Video: Sanofi Pasteur Announces Final Results of U.S. Clinical Trials of Influenza A (H1N1) Vaccine in Adults and Children
- Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
More News related to SNY
- New GoMeals(TM) iPhone Application from sanofi-aventis U.S. to Help People with Diabetes Eat Healthy Anywhere, Anytime
- VerifyNow(R) System Highlighted in POPular Study Comparing Platelet Reactivity Tests
- Beacon Equity Issues Technical Trading Overview for Questcor Pharmaceuticals Inc.
- Trading Overview for Poniard Pharmaceuticals Inc. Issued by Beacon Equity
- Notable Analyst Rating Changes 11/16: COH, JWN, GNK, ESEA, SVA, YGE Upgraded; PARD, GPS, JCP, DLTR Downgraded
More News related to Press Releases
- RW Baird Makes Positive Comments on Incyte (INCY) Following Novartis Deal
- Incyte (INCY) Strikes Major Drug Development Deal with Noavartis
- Human Genome Sciences (HGSI) Submits BLA to U.S. FDA for Hep C Treatment ZALBIN
- Incyte (INCY) In License Agreement With Novartis, Worth Up to $1 Billion
- Gen-Probe (GPRO) Gets U.S. FDA Clearance for Marketing Prodesse's ProParaflu+ Assay
PARIS--(BUSINESS WIRE)-- Sanofi-aventis, one of the world's largest diversified healthcare companies, reports earnings for the third-quarter of 2009. CEO Chris Viehbacher comments on Q3 earnings, recent partnerships and acquisitions, and outlook.
Use these links to watch the video interview in the format of your choice:
Windows Media Player:
http://www.eurobusinessmedia.com/interviewWmp.php?id_article=486
Flash Player:
http://www.eurobusinessmedia.com/interviewFlash.php?id_article=486
Use this link to read the interview transcript:
http://www.eurobusinessmedia.com/transcript.php?id_article=486
Topics covered in the interview include:
1. Comments on Q3 performance
2. Topline growth drivers
3.
Plavix & Eloxatin generic erosion
4. Multaq launch update
5.
H1N1 vaccine update
6. 2009 EPS guidance update
7.
Transforming Program
8. Merial deal update
9. Acquisition
strategy
10. Ambition for 2013
About Sanofi-aventis:
Sanofi-aventis, a leading global diversified healthcare company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT : SAN) and in New York (NYSE : SNY).
Company website: http://en.sanofi-aventis.com/home.asp
Source: Sanofi-aventis
Related Categories
Press ReleasesStocks Mentioned
+0.30Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
